Skip to main content
Sign In

University of Colorado Denver Hematology, Blood Cancer, Bone Marrow Transplant Program News

 Blood Cancer, Bone Marrow Transplant Program Logo


News and Highlights from the Blood Cancer and BMT Program

Behind the Scrubs: Sarah Strozinski

Hear from Sarah Strozinski, RN, BSN, OCN in our new series Behind the Scrubs published in the Bloodline newsletter.

How "SMART" are your Goals?


Research tells us that when implementing any new goal for yourself, it is helpful to make your goal specific, obtainable, manageable, and relevant to you. You may be asking yourself “How do I go about making, and specifying, a goal for myself?”

Professor Doug Graham Publishes Leading Article on New Cancer Therapies

In the featured article in the December issue of Nature Reviews Cancer, Dr. Graham describes the emerging field of TAM family kinases and their potential as therapeutic targets in leukemia and other forms of cancer.

Dr. Daniel Pollyea Reports the Latest Results from a New Leukemia Drug

Speaking at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, Dr. Pollyea summarized the latest results for AG-120, an exciting new drug for the treatment of patients with advanced leukemia.

Rachel Rabinovitch Represents CU Cancer Center in Jerusalem and Tel Aviv

Israel has the highest BRCA+ prevalence of any nation. Rabinovitch will deliver lectures and collaborate with health professionals who have expertise with the BRCA+ population in Israel.

Welcome Dr. Manali Kamdar

We are very pleased to announce that Dr. Manali Kamdar will be joining us in late November as a new attending physician and Assistant Professor in the Division of Hematology.

Benjamin Brewer Awarded NCCN Grant

"If patients are having difficulties taking their medications, I want to provide the physicians with strategies to help their patients stay on schedule," says Brewer.

Nurse Navigators Help Patients Find Needed Care

Read how the Blood Cancer program's Christine Frodella and other nurse navigators support patients at the University of Colorado Cancer Center

Experimental Drugs Approved Faster

81-year-old Larry Rosenberg credits an experimental drug with saving his life from chronic lymphocytic leukemia. Now the Break Through Therapy Provision will help other patients get faster access to experimental drugs as well.

KCBO Radio Interview with Emily

KCBO radio interview with our patient Emily about her experience with blood cancer. Her doctors treated her for an aggressive form of leukemia.

Five Questions for Jennifer Caspari

Psychological wellness of cancer patients often influences health outcomes. Jennifer Caspari spends much of her time building relationships with patients, especially those involved with stem cell transplants, to help their recovery.

New Leukemia Treatment

Larry Rosenberg is a leukemia patient. Dan Pollyea, MD, is treating Rosenberg. And Michael Bennet is a U.S. senator from Colorado who helped fast-track a drug that is helping Rosenberg and patients like him.